is tirzepatide a glp Explained: The Future of Weight Management Tirzepatide 10mg — GLP-1/GIP Dual-Agonist

Semaglutide , a glucagon-like peptide-1 (GLP-1) agonist, is a medication used for weight loss, type 2 diabetes management, and cardiovascular risk reduction

Q2 2025 Snapshot Eli Lilly and Company dominates the US 57 % GLP-1 share, led by Mounjaro (tirzepatide) HCP & Zepbound (tirzepatide) HCP Novo Nordisk rules Europe 63 % value share, powered by Wegovy(semaglutide) injection 2.4 mg HCP & Ozempic APAC & Emerging Markets are the next frontier (+1113 % YoY) Together, they crossed $24 Billion in H1 2025 GLP-1 revenue proving the real blockbuster of this decade isnt oncology or immunology Its metabolic health

All are HSA/FSA eligible, require no insurance, and come from licensed 503A compounding pharmacies

Transparent communication about all symptomsmood, physical, and metabolicenables coordinated decision-making

Holst, Damien J

Common side effects include nausea, vomiting, diarrhea, constipation, headache, dizziness, and injection site reactions